Clinical Trials · NCT00667069
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- UNICANCER
- Enrollment
- 424
- Start date
- Apr 2008
- Locations
- 17 sites, France
- Primary endpoint
- Event-free survival